Becton, Dickinson Recieves FDA Clearance for Surgiphor 1000 ml Irrigation System

Core Insights - Becton, Dickinson and Company (BDX) is recognized as one of the 13 undervalued dividend aristocrats to consider for investment [1] - BDX is a leading global medical technology company, focusing on innovation in medical essentials, connected care, biopharma systems, and interventional solutions [2] FDA Clearance and Product Innovation - BDX received FDA 510(k) clearance for its Surgiphor™ 1000mL irrigation system, designed for powered lavage procedures, which provides a standardized and sterile solution for wound care [3][4] - The Surgiphor™ portfolio now includes both manual and powered irrigation options, enhancing flexibility for healthcare providers [4] - The company aims for an adjusted EPS of $12.35 to $12.65 for FY 2026, indicating a projected growth of 6% at the midpoint compared to the previous year [4]